The macrophage migration inhibitory factor (MIF) as a therapeutic and diagnostic target

Christine Landlinger-Schubert, PhD, OncoOne, Klosterneuburg, Austria, talks on the macrophage migration inhibitory factor (MIF) as a target for the treatment of both solid tumors and chronic inflammatory diseases, as well as a diagnostic tool. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.

• #education
• #speaker_christine_landlinger_schubert
• #institution_oncoone
• #event_wclc_2022
• #format_interview
• #subject_lung_cancer
• #field_treatment
• #medicines_antibodies
• #medicines_on203
• #field_immuno_oncology
• #field_diagnosis